Report #2840524

Received May 12, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 45 yrs
State: AZ
Recovered: Recovered
Vaccinated: Oct 10, 2024
Onset: Oct 10, 2024
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
SMALLMNK	SMALLPOX + MONKEYPOX (JYNNEOS)	BAVARIAN NORDIC	1	FDP00016	IM / LA

Symptoms (1)

No adverse event

Symptom narrative

The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reactions reported.

Current illness

None reported

Medical history

Asymptomatic human immunodeficiency virus infection Encounter for screening for human papillomavirus (HPV) Anal warts Adjustment disorder with mixed anxiety and depressed mood Anxiety Syphilis Dysplasia of anus Hypercholesteremia Anal intraepithelial neoplasia I (AIN I) Cannabis use, uncomplicated Mild benzodiazepine use disorder Attention deficit hyperactivity disorder (ADHD) Pruritus Papanicolaou smear of anus with atypical squamous cells of undetermined significance (ASC-US)

Other medications

abacavir-dolutegravir-lamivud (TRIUMEQ) 600-50-300 mg tablet loratadine (CLARITIN) 10 mg tab Hydroxyzine (ATARAX) 50 mg tablet cholecalciferol, VITAMIN D3, 50 mcg (2,000 unit) calcium carb/magnesium ox,carb (CAL-MAG ORAL) Cod Liver Oil amin

Allergies

NKDA

Lab data

N/A